Litigation Details for Novartis Pharmaceuticals Corporation v. Natco Pharma Ltd. (D. Del. 2015)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. Natco Pharma Ltd. (D. Del. 2015)
Docket | ⤷ Try a Trial | Date Filed | 2015-10-28 |
Court | District Court, D. Delaware | Date Terminated | 2017-01-03 |
Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
Jury Demand | None | Referred To | |
Patents | 6,894,051; RE43,932 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Natco Pharma Ltd.
Details for Novartis Pharmaceuticals Corporation v. Natco Pharma Ltd. (D. Del. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2015-10-28 | 1 | THE PATENTS IN SUIT 15. United States Patent No. 6,894,051 (the “’051 Patent”) duly …the ’051 Patent. 17. United States Reissue Patent No. RE43,932 (the “RE932 Patent”) duly…of the ’051 Patent and the RE932 Patent, would constitute infringement of the ’051 Patent and the RE932…date on which last-expiring patent of the ’051 Patent and the RE932 Patent expires, including any associated… This is an action for patent infringement arising under the patent laws of the United States, | External link to document | |
2015-10-28 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,894,051; RE43,932;. (dmp, )…2015 4 January 2017 1:15-cv-00987 830 Patent None District Court, D. Delaware | External link to document | |
2017-02-21 | 43 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,894,051; RE43,932. (etg) (Entered…2015 4 January 2017 1:15-cv-00987 830 Patent None District Court, D. Delaware | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |